These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: [Ovarian stimulation with gonadotropins: comparison between recombinant FSH plus menotropins versus recombinant FSH + LH].
    Author: Santibáñez Morales A, Colín Licea EO, Durán Boullosa E, Sánchez Serrano P, Pashkova O.
    Journal: Ginecol Obstet Mex; 2014 May; 82(5):307-13. PubMed ID: 24937946.
    Abstract:
    BACKGROUND: Nowadays various assisted reproduction ovarian stimulation schemes are used for different clinical outcomes is interesting to compare. OBJECTIVE: Compare two ovarian stimulation protocols: recombinant FSH + LH versus recombinant FSH + Menotropins. MATERIAL AND METHODS: Observational, retrospective study, 38 cycles were analyzed, made from 2010 until 2013, assigned to two groups (n = 19 each), group 1 received FSHr + LHr, group 2 received FSHr + menotropins. Study variables were: days of ovarian stimulation, total gonadotropin dose, retrieved oocytes, fertilization rate, pregnancy rate and number of vitrified embryos. RESULTS: Fewer stimulation days (8.5 +/- 1.5 vs 9 +/- 1.1) were found in group 1 (recombinant gonadotropins). Group 2 (FSHr + Menotropins), had a greater total dose of gonadotropins (1930.2 +/- 346.2 vs 2000 +/- 418.8) and more retrieved oocytes (8.15 +/- 3.9 vs 8.57 +/- 4). Group 1 patients had higher pregnancy and fertilization rates (56.2 vs 36.8%, and 75.4 vs 69.3%) respectively, no statistical significance was found. CONCLUSION: This study found higher pregnancy and fertilization rates in patients treated with recombinant gonadotropins (FSH + LH) for ovarian stimulation.
    [Abstract] [Full Text] [Related] [New Search]